Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDXS NASDAQ:GEVO NASDAQ:GPRE NYSE:WLKP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDXSCodexis$2.49+2.0%$2.79$1.90▼$6.08$220.25M2.541.04 million shs404,434 shsGEVOGevo$1.89+4.4%$1.57$0.92▼$3.39$437.73M2.183.53 million shs5.99 million shsGPREGreen Plains$10.32+4.5%$8.88$3.14▼$14.04$647.79M1.222.09 million shs2.90 million shsWLKPWestlake Chemical Partners$21.57-0.8%$22.04$21.41▼$25.04$766.44M0.7632,266 shs25,616 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDXSCodexis+0.41%-0.41%-18.94%+9.91%-12.23%GEVOGevo+8.38%+10.37%+0.56%+35.07%+54.70%GPREGreen Plains+2.60%-2.18%+17.06%+70.93%-21.46%WLKPWestlake Chemical Partners-0.14%-0.93%-1.18%-1.36%-2.99%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDXSCodexis$2.49+2.0%$2.79$1.90▼$6.08$220.25M2.541.04 million shs404,434 shsGEVOGevo$1.89+4.4%$1.57$0.92▼$3.39$437.73M2.183.53 million shs5.99 million shsGPREGreen Plains$10.32+4.5%$8.88$3.14▼$14.04$647.79M1.222.09 million shs2.90 million shsWLKPWestlake Chemical Partners$21.57-0.8%$22.04$21.41▼$25.04$766.44M0.7632,266 shs25,616 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDXSCodexis+0.41%-0.41%-18.94%+9.91%-12.23%GEVOGevo+8.38%+10.37%+0.56%+35.07%+54.70%GPREGreen Plains+2.60%-2.18%+17.06%+70.93%-21.46%WLKPWestlake Chemical Partners-0.14%-0.93%-1.18%-1.36%-2.99%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDXSCodexis 2.50Moderate Buy$11.00341.77% UpsideGEVOGevo 2.33Hold$7.58300.79% UpsideGPREGreen Plains 2.13Hold$8.83-14.41% DownsideWLKPWestlake Chemical Partners 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest CDXS, GEVO, GPRE, and WLKP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025GPREGreen PlainsOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$14.008/28/2025WLKPWestlake Chemical PartnersZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold8/14/2025GPREGreen PlainsBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral ➝ Underperform$4.50 ➝ $7.008/13/2025GEVOGevoZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/11/2025GPREGreen PlainsZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDXSCodexis$59.35M3.79N/AN/A$0.82 per share3.04GEVOGevo$16.92M27.01N/AN/A$2.04 per share0.93GPREGreen Plains$2.46B0.28N/AN/A$13.53 per share0.76WLKPWestlake Chemical Partners$1.14B0.67$4.90 per share4.40$23.53 per share0.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDXSCodexis-$65.28M-$0.83N/AN/AN/A-113.67%-105.83%-46.06%10/30/2025 (Estimated)GEVOGevo-$78.64M-$0.26N/AN/AN/A-72.76%-12.04%-9.09%11/6/2025 (Estimated)GPREGreen Plains-$82.50M-$2.400.0013.23N/A-6.34%-13.65%-6.72%10/30/2025 (Estimated)WLKPWestlake Chemical Partners$62.39M$1.4914.6012.692.744.78%6.38%4.00%11/4/2025 (Estimated)Latest CDXS, GEVO, GPRE, and WLKP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025CDXSCodexis-$0.17-$0.16+$0.01-$0.16$14.18 million$15.33 million8/11/2025Q2 2025GEVOGevo-$0.06$0.01+$0.07$0.01$43.69 million$43.41 million8/11/2025Q2 2025GPREGreen Plains-$0.28-$0.41-$0.13-$1.09$578.18 million$552.83 million8/5/2025Q2 2025WLKPWestlake Chemical Partners$0.44$0.41-$0.03$0.41$301.00 million$297.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDXSCodexisN/AN/AN/AN/AN/AGEVOGevoN/AN/AN/AN/AN/AGPREGreen PlainsN/AN/AN/AN/AN/AWLKPWestlake Chemical Partners$1.898.77%N/A126.85%N/ALatest CDXS, GEVO, GPRE, and WLKP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/30/2025WLKPWestlake Chemical Partnersquarterly$0.47148.6%8/12/20258/12/20258/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDXSCodexis0.715.825.70GEVOGevo0.292.332.10GPREGreen Plains0.581.470.94WLKPWestlake Chemical Partners0.482.152.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDXSCodexis78.54%GEVOGevo35.17%GPREGreen PlainsN/AWLKPWestlake Chemical Partners78.28%Insider OwnershipCompanyInsider OwnershipCDXSCodexis1.90%GEVOGevo4.00%GPREGreen Plains1.00%WLKPWestlake Chemical Partners1.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDXSCodexis25090.27 million88.55 millionOptionableGEVOGevo100241.84 million232.17 millionOptionableGPREGreen Plains90065.57 million64.91 millionOptionableWLKPWestlake Chemical Partners15035.24 million34.85 millionOptionableCDXS, GEVO, GPRE, and WLKP HeadlinesRecent News About These CompaniesWhat If the Fed Cuts 50 Basis Points? 4 Ultra-High-Yield Favorites Will ExplodeSeptember 9, 2025 | 247wallst.comWall Street Zen Downgrades Westlake Chemical Partners (NYSE:WLKP) to HoldSeptember 8, 2025 | marketbeat.comEnergy Income Partners LLC Trims Stake in Westlake Chemical Partners LP $WLKPSeptember 2, 2025 | marketbeat.comWestlake Chemical Partners (NYSE:WLKP) Stock Rating Upgraded by Zacks ResearchSeptember 1, 2025 | marketbeat.comInsider Buying: Westlake Chemical Partners (NYSE:WLKP) CEO Purchases 1,250 Shares of StockAugust 30, 2025 | marketbeat.comWestlake Chemical Partners (NYSE:WLKP) CEO Purchases $102,648.00 in StockAugust 30, 2025 | marketbeat.comPresident and CEO Of Westlake Chemical Purchased $163K In StockAugust 29, 2025 | benzinga.comWestlake Chemical Partners (NYSE:WLKP) CEO Purchases $27,325.00 in StockAugust 29, 2025 | insidertrades.com163K Reasons To Be Bullish On Westlake Chemical StockAugust 28, 2025 | benzinga.comWall Street Zen Upgrades Westlake Chemical Partners (NYSE:WLKP) to "Buy"August 27, 2025 | marketbeat.comWestlake Chemical Partners (NYSE:WLKP) Cut to Hold at Wall Street ZenAugust 18, 2025 | marketbeat.comWestlake Chemical Partners LP (NYSE:WLKP) Shares Sold by Invesco Ltd.August 16, 2025 | marketbeat.com3 Dividend Stocks With Over 8% Yield To Buy In AugustAugust 7, 2025 | 247wallst.comWestlake Chemical Partners LP (NYSE:WLKP) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | insidermonkey.comWLKP Earnings Miss by 13%August 5, 2025 | fool.comWestlake Chemical Partners LP Common Units (WLKP) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comWestlake Chemical Partners LP Common Units 2025 Q2 - Results - Earnings Call PresentationAugust 5, 2025 | seekingalpha.comWestlake Chemical Partners LP earnings missed by $0.04, revenue fell short of estimatesAugust 5, 2025 | investing.comWestlake Chemical Partners LP (WLKP) Q2 2025 Earnings Report Preview: What to Look ForAugust 4, 2025 | gurufocus.comWestlake Chemical Partners LP Announces Second Quarter 2025 DistributionJuly 30, 2025 | finance.yahoo.comWestlake: Down 30%+ Since My Last Article, Looking Into 2025EJuly 16, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCDXS, GEVO, GPRE, and WLKP Company DescriptionsCodexis NASDAQ:CDXS$2.49 +0.05 (+2.05%) Closing price 04:00 PM EasternExtended Trading$2.50 +0.01 (+0.36%) As of 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.Gevo NASDAQ:GEVO$1.89 +0.08 (+4.42%) Closing price 04:00 PM EasternExtended Trading$1.89 0.00 (-0.05%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.Green Plains NASDAQ:GPRE$10.32 +0.44 (+4.45%) Closing price 04:00 PM EasternExtended Trading$10.35 +0.03 (+0.33%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Green Plains Inc. produces low-carbon fuels in the United States and internationally. It operates through three segments: Ethanol Production, Agribusiness and Energy Services, and Partnership. The Ethanol Production segment produces ethanol, distillers grains, and ultra-high protein and renewable corn oil. The Agribusiness and Energy Services segment engages in the grain procurement, handling and storage, commodity marketing business; and trading of ethanol, distiller grains, renewable corn oil, grain, natural gas, and other commodities in various markets. This segment also provides grain drying and storage services to grain producers. The Partnership segment offers fuel storage and transportation services. It operates 24 ethanol storage facilities; two fuel terminal facilities; and a fleet of approximately 2,180 leased railcars. The company was formerly known as Green Plains Renewable Energy, Inc. and changed its name to Green Plains Inc. in May 2014. Green Plains Inc. was incorporated in 2004 and is headquartered in Omaha, Nebraska.Westlake Chemical Partners NYSE:WLKP$21.57 -0.18 (-0.83%) Closing price 03:59 PM EasternExtended Trading$21.58 +0.01 (+0.05%) As of 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. Westlake Chemical Partners LP was founded in 1991 and is headquartered in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Resideo Technologies: Institutional Activity Signals 30% Upside Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Uranium Energy Stock Has Momentum—and More Upside Ahead Why Opendoor Stock Is Soaring—and May Just Be Starting Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
